{"id":"W2240235803","doi":"10.1200/jco.2009.27.15_suppl.5591","title":"A phase II study of aflibercept (VEGF trap) in recurrent or metastatic gynecologic soft-tissue sarcomas: A study of the Princess Margaret Hospital Phase II Consortium","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Aflibercept; Leiomyosarcoma; Adverse effect; Bevacizumab; Internal medicine; Surgery; Phases of clinical research; Sarcoma; Gastroenterology; Oncology; Chemotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004405177,0.000295895,0.003223453,0.0002642383,0.0001056656,0.000006771482,0.0005652063,0.0002005532,0.0002071705],"category_scores_gemma":[0.004602668,0.0001618105,0.0006932567,0.0005737393,0.0002971101,0.000120675,0.0001923752,0.001303892,0.000001168213],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001166362,"about_ca_system_score_gemma":0.001129049,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002812239,"about_ca_topic_score_gemma":0.0003980858,"domain_scores_codex":[0.9919062,0.001741782,0.004775883,0.0003665604,0.0008243122,0.0003853036],"domain_scores_gemma":[0.9938894,0.001401853,0.003426144,0.0005034223,0.0004585528,0.0003206284],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"nonrandomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.0125211,0.5747164,0.04048884,0.00006714398,0.001064473,0.00371091,0.009209121,0.00002080413,0.0003442082,0.00002374,0.0006781207,0.3571551],"study_design_scores_gemma":[0.1146589,0.6549279,0.2148707,0.0001967774,0.001639752,0.0002673424,0.0103437,0.00008693714,0.00008598385,0.0001642615,0.002585392,0.0001723098],"study_design_candidate":"nonrandomized_trial","study_design_consensus":"nonrandomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933003,0.0005553959,0.00002689672,0.003136035,0.0007758013,0.002075402,0.000008318389,0.000009024218,0.0001127863],"genre_scores_gemma":[0.9985915,0.0001144131,0.0004759233,0.0004528391,0.0002119342,0.00001779171,0.000001627575,0.00001832981,0.0001156452],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3569828,"threshold_uncertainty_score":0.6598439,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1095529008604727,"score_gpt":0.4744979455907162,"score_spread":0.3649450447302435,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}